Vascular Disrupting Agent Drug Classes Differ in Effects on the Cytoskeleton

Open Access

Peer-reviewed

Research Article

Sujeong Kim ,

* E-mail: Sujeong_Kim@hms.harvard.edu

Affiliation Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, United States of America
⨯
Leonid Peshkin,

Affiliation Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, United States of America
⨯
Timothy J. Mitchison

Affiliation Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, United States of America
⨯

Reader Comments (0)

Microtubules
Is the Subject Area "Microtubules" applicable to this article?

Thanks for your feedback.
Tubulins
Is the Subject Area "Tubulins" applicable to this article?

Thanks for your feedback.
Actins
Is the Subject Area "Actins" applicable to this article?

Thanks for your feedback.
Endothelial cells
Is the Subject Area "Endothelial cells" applicable to this article?

Thanks for your feedback.
Actin polymerization
Is the Subject Area "Actin polymerization" applicable to this article?

Thanks for your feedback.
Malignant tumors
Is the Subject Area "Malignant tumors" applicable to this article?

Thanks for your feedback.
Polymerization
Is the Subject Area "Polymerization" applicable to this article?

Thanks for your feedback.
Cytoskeleton
Is the Subject Area "Cytoskeleton" applicable to this article?

Thanks for your feedback.